Outcome | 37Â weeks | 35Â weeks | ||||
---|---|---|---|---|---|---|
Unadjusted OR (95% CI) | Adjusted OR (95% CI)a | P-Value | Unadjusted OR (95% CI) | Adjusted OR (95% CI)a | P-value | |
Antidepressant use | ||||||
 No exposure | – | – | – | – | – | – |
 Exposure | 2.13 (1.36–3.32) | 2.17 (1.37–3,44) | .001 | 2.14 (1.34–3.42) | 2.21 (1.37–3.58) | .001 |
Type of antidepressant | ||||||
 TCAs | 1.92 (0.60–6.11) | 1,98 (0.62–6.34) | .252 | 2.20 (0.69–7.02) | 2,31 (0.72–7.44) | .161 |
 SSRIs | 2.15 (1.29–3.57) | 2.14 (1.28–3.60) | .004 | 2.08 (1.21–3.57) | 2.09 (1.20–3.64) | .009 |
 MAOI | – | – | – | – | – | – |
 RIMA | – | – | – | – | – | – |
 Other | 1.62 (0.39–6.63) | 1.64 (0.40–6.78) | .495 | 1.92 (0.47–7.92) | 1.98 (0.48–8.23) | .348 |
DDD | ||||||
  ≤ 30 | 0.72 (0.18–2.90) | 0,79 (0.19–3.23) | .744 | 1.35 (0.43–4.27) | 1.45 (0.46–4.62) | .529 |
  ≥ 30 | 2.68 (1.68–4.29) | 2.65 (1.63–4.29) | <.001 | 2.41 (1.45–4.01) | 2.44 (1.45–4.11) | .001 |
DDD SSRIs | ||||||
  ≤ 30 | 0.54 (0.07–3.90) | 0.59 (0.08–4.31) | .607 | 1.48 (0.36–6.06) | 1.57 (0.38–6.49) | .532 |
  ≥ 30 | 2.68 (1.68–4.29) | 2.65 (1.63–4.28) | .001 | 2,23 (1.24–3.99) | 2.20 (1.21–3.98) | .010 |
Period | ||||||
 0–10 weeks | 2.21 (1.40–3.49) | 2.25 (1.41–3.61) | .001 | 2.32 (1.43–3.74) | 2.38 (1.46–3.90) | .001 |
 11–20 weeks | 2.48 (1.47–4.20) | 2.48 (1.45–4.26) | .001 | 2.42 (1.43–4.10) | 2.44 (1.43–4.20) | .001 |
 0–10 weeks only | 1.56 (0.69–3.54) | 1.64 (0.71–3.74) | .242 | 1.50 (0.55–4.07) | 1.59 (0.58–4.35) | .365 |
 Both periods (0–20 weeks) | 2.69 (1.56–4.64) | 2,69 (1.53–4.68) | .001 | 2.74 (1.59–4.73) | 2.75 (1.58–4.82) | <.001 |
Maternal age | ||||||
 15–19 | – | – | – | – | – | – |
 20–24 | 1.31 (0.18–9.68) | – | .790 | 1.77 (0.24–13.15) | – | .579 |
 25–29 | 1.97 (0.80–4.86) | – | .143 | 1.75 (0.64–4.78) | – | .278 |
 30–34 | 2,88 (1.49–5.53) | – | .002 | 2.89 (1.45–5.75) | – | .003 |
 34–39 | 1.29 (0.40–4.17) | – | .666 | 1.37 (0.42–4.41) | – | .600 |
 40+ | 1.30 (0.29–5.73) | – | .729 | 1.30 (0.29–5.73) |  | .729 |